Literature DB >> 6956913

Successful immunization with a totally synthetic diphtheria vaccine.

F Audibert, M Jolivet, L Chedid, R Arnon, M Sela.   

Abstract

Three peptides corresponding to fragments of diphtheria toxin have been synthesized. They include the previously described tetradecapeptide and two structural analogs, the hexadecapeptide and the octadecapeptide. Conjugates of these peptides to proteins or a synthetic carrier have induced in guinea pig protection against the dermonecrotic activity of diphtheria toxin. All of the conjugates were immunogenic when administered either in complete Freund's adjuvant or with N-acetylmuramyl-L-alanyl-D-isoglutamine in aqueous medium. Positive immune response toward the octadecapeptide was obtained in mice as well. In this case, the immunogenic combinations were conjugates with bovine serum albumin administered either in Freund's adjuvant or with the muramyl dipeptide and a complete synthetic conjugate comprising both the octadecapeptide and the muramyl dipeptide covalently attached to a synthetic carrier, multichain poly(DLAla). This last immunogen, which induced the most effective immune response, is a completely synthetic immunogen with built-in adjuvanticity and induces protective antitoxic immunity when administered in a physiological medium.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6956913      PMCID: PMC346823          DOI: 10.1073/pnas.79.16.5042

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

Review 1.  Diphtheria toxin: mode of action and structure.

Authors:  R J Collier
Journal:  Bacteriol Rev       Date:  1975-03

2.  Distinctive adjuvanticity of synthetic analogs of mycobacterial water-soluble components.

Authors:  F Audibert; L Chédid; P Lefrancier; J Choay
Journal:  Cell Immunol       Date:  1976-02       Impact factor: 4.868

3.  Total synthesis and adjuvant activity of bacterial peptidoglycan derivatives.

Authors:  C Merser; P Sinay; A Adam
Journal:  Biochem Biophys Res Commun       Date:  1975-10-27       Impact factor: 3.575

Review 4.  Diphtheria toxin.

Authors:  A M Pappenheimer
Journal:  Annu Rev Biochem       Date:  1977       Impact factor: 23.643

5.  Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives.

Authors:  F Ellouz; A Adam; R Ciorbaru; E Lederer
Journal:  Biochem Biophys Res Commun       Date:  1974-08-19       Impact factor: 3.575

Review 6.  Antigenicity: some molecular aspects.

Authors:  M Sela
Journal:  Science       Date:  1969-12-12       Impact factor: 47.728

7.  Antibodies reactive with native lysozyme elicited by a completely synthetic antigen.

Authors:  R Arnon; E Maron; M Sela; C B Anfinsen
Journal:  Proc Natl Acad Sci U S A       Date:  1971-07       Impact factor: 11.205

8.  Immunoadjuvant activities of cell walls, their water-soluble fractions and peptidoglycan subunits, prepared from various gram-positive bacteria, and of synthetic n-acetylmuramyl peptides.

Authors:  S Kotani; Y Watanabe; T Shimono; T Narita; K Kato
Journal:  Z Immunitatsforsch Exp Klin Immunol       Date:  1975-07

9.  [Enhancement of the immune response to influenza vaccine by a synthetic glycopeptide adjuvant (N-acetyl muramy1-L-analyl-D-isoglutamine)].

Authors:  F Audibert; L Chedid; C Hannoun
Journal:  C R Acad Hebd Seances Acad Sci D       Date:  1977-09-12

10.  Antiviral effect on MS-2 coliphage obtained with a synthetic antigen.

Authors:  H Langbeheim; R Arnon; M Sela
Journal:  Proc Natl Acad Sci U S A       Date:  1976-12       Impact factor: 11.205

View more
  24 in total

Review 1.  Where are we in the quest for vaccines for malaria?

Authors:  W A Siddiqui
Journal:  Drugs       Date:  1991-01       Impact factor: 9.546

Review 2.  New aspects of vaccine development.

Authors:  F Y Liew
Journal:  Clin Exp Immunol       Date:  1985-11       Impact factor: 4.330

3.  Immunotoxicity of immunotherapeutic agents.

Authors:  A G Johnson; J Regal
Journal:  Springer Semin Immunopathol       Date:  1985

4.  Enhanced epitopic response to a synthetic human malarial peptide by preimmunization with tetanus toxoid carrier.

Authors:  L D Lise; D Mazier; M Jolivet; F Audibert; L Chedid; D Schlesinger
Journal:  Infect Immun       Date:  1987-11       Impact factor: 3.441

5.  Induction of biologically active antibodies by a polyvalent synthetic vaccine constructed without carrier.

Authors:  M E Jolivet; F M Audibert; H Gras-Masse; A L Tartar; D H Schlesinger; R Wirtz; L A Chedid
Journal:  Infect Immun       Date:  1987-06       Impact factor: 3.441

6.  Epitope-specific protective immunogenicity of chemically synthesized 13-, 18-, and 23-residue peptide fragments of streptococcal M protein.

Authors:  E H Beachey; A Tartar; J M Seyer; L Chedid
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

7.  Depressed chemiluminescence response by influenza virus is enhanced after conjugation of viral subunits to muramyl dipeptide.

Authors:  K N Masihi; W Lange; B Rohde-Schulz; L Chedid; M Jolivet
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

8.  MER5101, a novel Aβ1-15:DT conjugate vaccine, generates a robust anti-Aβ antibody response and attenuates Aβ pathology and cognitive deficits in APPswe/PS1ΔE9 transgenic mice.

Authors:  Bin Liu; Jeffrey L Frost; Jing Sun; Hongjun Fu; Stephen Grimes; Peter Blackburn; Cynthia A Lemere
Journal:  J Neurosci       Date:  2013-04-17       Impact factor: 6.167

9.  New approaches for control of infections using synthetic or semi-synthetic constructs containing MDP.

Authors:  L Chedid; F Audibert
Journal:  Springer Semin Immunopathol       Date:  1985

Review 10.  HLA-DR: molecular insights and vaccine design.

Authors:  Lawrence J Stern; J Mauricio Calvo-Calle
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.